What is the appropriate symptomatic treatment for a patient presenting with sore throat, nasal irritation, rhinorrhea and low‑grade fever?

Treatment of Acute Viral Upper Respiratory Infection with Sore Throat

For a patient presenting with sore throat, nasal irritation, rhinorrhea, and low-grade fever, provide symptomatic treatment only with analgesics and nasal saline irrigation—antibiotics are not indicated and should not be prescribed. 1

First-Line Symptomatic Management

Analgesics for Pain and Fever Control

• Acetaminophen (paracetamol) 1000 mg every 4-6 hours (maximum 4000 mg/24 hours) is the preferred first-line agent due to its superior safety profile with no gastrointestinal bleeding risk, no adverse renal effects, and no cardiovascular toxicity compared to NSAIDs. 1
• Alternatively, NSAIDs such as ibuprofen can be used for pain relief and fever control if acetaminophen is contraindicated or insufficient. 2, 1
• Throat lozenges may provide additional topical relief for sore throat discomfort. 2

Nasal Symptom Relief

• Nasal saline irrigation 2-3 times daily provides cleansing and modest symptom relief by facilitating clearance of nasal secretions and reducing congestion. 1
• Oral decongestants (e.g., pseudoephedrine) may relieve nasal congestion but should be avoided in patients with hypertension, anxiety, cardiac arrhythmia, angina, cerebrovascular disease, bladder-neck obstruction, or glaucoma. 1
• Topical nasal decongestants (e.g., oxymetazoline) may be used for severe congestion only for 3-5 days maximum to prevent rebound congestion (rhinitis medicamentosa). 1

Adjunctive Therapies

• Zinc lozenges (≥75 mg/day of zinc acetate or gluconate) started within 24 hours of symptom onset may reduce illness duration, though benefits must be weighed against adverse effects including nausea and bad taste. 1
• Combination antihistamine-analgesic-decongestant products provide significant symptom relief in approximately 1 out of 4 patients treated. 1

What NOT to Do: Antibiotic Stewardship

Antibiotics should never be prescribed for this presentation because: 2, 1

• The symptom constellation of rhinorrhea, cough, sore throat, and low-grade fever strongly indicates viral etiology. 1
• Symptoms present for fewer than 7-10 days are unlikely to represent bacterial infection. 1
• Antibiotics provide no benefit for viral infections, do not prevent complications (bacterial sinusitis, asthma exacerbation, or otitis media), and cause adverse effects in 40-43% of patients. 1
• Purulent (colored) nasal discharge reflects normal neutrophil activity in viral infection and should not trigger antibiotic therapy. 1

When to Test for Bacterial Pharyngitis

Testing for group A streptococcal pharyngitis is not indicated in this case because the presence of rhinorrhea, cough, and nasal symptoms strongly argues against bacterial pharyngitis. 1

If bacterial pharyngitis were suspected (persistent fever, anterior cervical adenitis, tonsillopharyngeal exudates without rhinorrhea/cough), then:

• Perform rapid antigen detection test and/or culture for group A Streptococcus. 2
• Prescribe antibiotics only if testing confirms streptococcal infection. 2

Expected Clinical Course and Patient Education

• Symptoms typically peak within 3 days and resolve within 10-14 days without specific treatment. 1
• Reassure patients that the illness is self-limited and will resolve without antibiotics. 2, 1
• Advise return for reassessment if symptoms persist ≥10 days without improvement, high fever ≥39°C with purulent nasal discharge and facial pain for ≥3-4 consecutive days, or worsening symptoms after initial improvement ("double-sickening"). 1

Common Pitfalls to Avoid

• Do not prescribe antibiotics based on purulent nasal discharge alone—this is a normal feature of viral colds reflecting neutrophil activity, not bacterial infection. 1
• Do not extend topical decongestant use beyond 3-5 days, as this leads to rebound congestion requiring prolonged therapy. 1
• Do not use intranasal corticosteroids for common cold symptomatic relief, as there is no evidence of benefit. 1
• Vitamin C and echinacea have no proven benefit for treating established viral upper respiratory infections. 1